Sartorius reduces revenue by €26M to refund Trump tariffs to customersnews2026-07-23T16:00:28+00:00July 23rd, 2026|Endpoints News|
Merck CEO cautions Congress on imposing limits on Chinese dealmakingnews2026-07-23T14:53:43+00:00July 23rd, 2026|Endpoints News|
Scancell plans Neuphoria merger; AstraZeneca wins EU nod for cancer drugnews2026-07-23T14:47:25+00:00July 23rd, 2026|Endpoints News|
Biogen counts on drugs from Apellis deal to patch Leqembi’s slow salesnews2026-07-23T14:00:25+00:00July 23rd, 2026|Endpoints News|
What’s behind the proposed pullback on remote patient monitoringnews2026-07-23T13:56:47+00:00July 23rd, 2026|Endpoints News|
Repligen’s $1.5B buy for BioLife; BeOne’s $300M US expansion news2026-07-23T13:01:21+00:00July 23rd, 2026|Endpoints News|
Lilly’s triple agonist heads to regulators after two more Phase 3 obesity winsnews2026-07-23T11:11:18+00:00July 23rd, 2026|Endpoints News|
Roche says it is thoughtful on token use for AI, shelves a drug from Carmot buynews2026-07-23T11:03:14+00:00July 23rd, 2026|Endpoints News|
Exclusive: Obesity biotech Verdiva hires ex-Metsera CMO as crucial readouts nearnews2026-07-23T10:30:33+00:00July 23rd, 2026|Endpoints News|
Teladoc is moving beyond its single-visit roots with new launchnews2026-07-23T10:00:41+00:00July 23rd, 2026|Endpoints News|